Zweig-DiMenna Associates »

Revolution Medicines shares owned by Zweig-DiMenna Associates

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Zweig-DiMenna Associates from 13F filings

Historical chart of Zweig-DiMenna Associates investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Zweig-DiMenna Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Zweig-DiMenna Associates

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.3M 105k 79.65

More positions owned by Zweig-DiMenna Associates

Amazon (AMZN)
Applovin Corp Com Cl A (APP)
Genedx Holdings Corp Com Cl A (WGS)
Broadcom (AVGO)
Microsoft Corp Call Option
Amazon Call Option
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Lumentum Hldgs (LITE)
Quanta Services (PWR)
NVIDIA Corporation (NVDA)
Hut 8 Corp (HUT)
Natera (NTRA)
Celestica (CLS)
Cyberark Software SHS (CYBR)
Alphabet Cap Stk Cl A Call Option

View all positions for Zweig-DiMenna Associates

Top funds holding Revolution Medicines

Vanguard Group
Farallon Capital Management
Henderson Group
Wellington Management Company
Baker Bros. Advisors
FMR
BlackRock
Nextech Invest
Paradigm Biocapital Advisors
Bellevue Group
State Street Corporation
BVF
Alphabet
Geode Capital Management
UBS Group

View all funds holding Revolution Medicines